Join
Live feed
·
INSIDERFilingvia Quantisnow
Chinook Therapeutics Inc. logo

SEC Form 4: Frohlich Tom sold $144,933 worth of shares (7,360 units at $19.69) and converted options into 13,582 shares, increasing direct ownership by 5% to 143,907 units (withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KDNY (Chinook Therapeutics Inc.) and more on Quantisnow.